100% Quality Guarantee
PhD-Level Technical Support
Key Features

APC Anti-Mouse CD22 Antibody [Cy34.1] (AGEL0731)

SKU AGEL0731
Product Type Antibody
Antibody Type Monoclonal Antibody
Reactivity Mouse
Applications FC
€108 - €238

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

APC Anti-Mouse CD22 Antibody [Cy34.1]

The Mouse CD22 Monoclonal Antibody (APC Conjugated, CY34.1) is a valuable tool for research in immunology and related fields. CD22 is a cell surface glycoprotein that plays a crucial role in B cell function, specifically in the regulation of B cell activation and signaling. This monoclonal antibody, conjugated with APC for enhanced detection, is specifically designed to bind to the CD22 protein, enabling its detection and analysis in various experimental settings.The CY34.1 antibody is highly specific to mouse CD22, making it an ideal choice for studies involving mouse models of immune responses, autoimmune diseases, and B cell-related disorders.

Its ability to target CD22 allows researchers to explore the functions of this important protein in regulating B cell development, activation, and tolerance.With its high reactivity and specificity, the Mouse CD22 Monoclonal Antibody (APC Conjugated, CY34.1) is a valuable resource for investigators conducting research in immunology, cancer biology, and autoimmune disease. By facilitating the identification and characterization of CD22-expressing cells, this antibody supports the advancement of knowledge in B cell biology and the development of potential therapeutics targeting CD22-mediated pathways.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose